课题基金 / 基金详情

Determination of circulation factors that mediate the health benefits of exercise in mitochondrial aging

Determination of circulation factors that mediate the health benefits of exercise in mitochondrial aging
确定调节运动对线粒体衰老健康益处的循环因素
批准号:
10011425
负责人:
TOMAS ALBERTO PROLLA
金额:
$25.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2022-08-31

项目摘要

项目成果

TOMAS ALBERTO PROLLA的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要/摘要: 这项提议旨在检验耐力运动刺激循环因子释放的假设 能够改善线粒体的适应性CyteGen的目标是识别这些内源性因子并对其进行工程改造 来治疗以线粒体功能障碍为核心的疾病。这些疾病包括神经变性 和其他与衰老有关的疾病,以及罕见的线粒体疾病, 编码线粒体蛋白的基因错误,影响5000人中的1人。目前,没有有效的 治疗是可用的。为了确定改善线粒体健康的因素,CyteGen正在使用一种独特的 小鼠模型,由PI创建。这个模型显示了一个深刻的线粒体综合征与减少的生活 由于POLG的外切核酸酶校正活性受损, 聚合酶。POLG在小鼠和人类之间是高度保守的,在这种聚合酶中有超过200个突变 与人类疾病有关,支持CyteGen的论点,即小鼠的发现将 翻译成人类。耐力运动逆转POLG突变小鼠早发性衰老综合征 通过克服线粒体功能中的POLG缺陷。对运动小鼠的组织分析表明, 内源性循环因子可能是原因我们将检验循环因子 通过从运动的POLG收集血浆来改善线粒体功能 将其注射到显示线粒体功能降低的老年POLG小鼠中 骨骼肌和心脏功能受损在模拟运动的注射时间表之后 训练,我们将检查代谢能力,心脏功能,自发活动水平和线粒体 功能本研究的第二个目的是使用基于细胞的模型来确定血浆的影响, 运动小鼠对POLG突变细胞的线粒体功能的影响。我们研究的目的是确定循环 逆转线粒体功能障碍的因子,具有合适的特性,以支持临床前研究的启动 准备临床评估。
英文摘要
Project Summary/Abstract: This proposal seeks to test the hypothesis that endurance exercise stimulates the release of circulating factors that improve mitochondrial fitness. CyteGen’s goal is to identify these endogenous factors and engineer them to treat diseases in which mitochondrial dysfunction is central. These diseases include neurodegenerative and other diseases associated with aging, as well as the rare mitochondrial diseases that arise from inborn errors in genes encoding mitochondrial proteins that affect 1 in 5000 individuals. Currently, no effective treatments are available. To identify factors that improve mitochondrial fitness, CyteGen is using a unique mouse model, created by the PI. This model displays a profound mitochondrial syndrome with reduced life span and premature aging due to impaired exonuclease proofreading activity of POLG, the sole mtDNA polymerase. POLG is highly conserved between mice and humans and over 200 mutations in this polymerase have been associated with human disease, supporting CyteGen’s contention that mouse discoveries will translate into humans. Endurance exercise of POLG mutant mice reverses the early-onset aging syndrome by overcoming the POLG defect in mitochondrial function. Analyses of tissues in exercised mice suggests that endogenous circulating factors may be responsible. We will test the hypothesis that circulating factors secreted as a result of exercise improve mitochondrial function by collecting plasma from exercised POLG mice and sedentary controls and injecting it into old POLG mice that display reduced mitochondrial function and impaired skeletal muscle and cardiac function. Following a schedule of injections that mimics exercise training, we will examine metabolic capacity, cardiac function, spontaneous activity levels and mitochondrial function. A second aim of this study is to use cell based models to determine the effects of plasma from exercised mice on mitochondrial function of POLG mutant cells. The goal of our studies is to identify circulating factors that reverse mitochondrial dysfunction with suitable properties to support initiation of preclinical studies in preparation for clinical evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of mitochondria in Age-Related Hearing Loss
  • 批准号:
    8292770
  • 项目类别:
  • 资助金额:
    $44.2万
  • 财政年份:
    2012
  • 负责人:
    TOMAS ALBERTO PROLLA
  • 依托单位:
The Role of mitochondria in Age-Related Hearing Loss
  • 批准号:
    9014535
  • 项目类别:
  • 资助金额:
    $36.76万
  • 财政年份:
    2012
  • 负责人:
    TOMAS ALBERTO PROLLA
  • 依托单位:
The Role of mitochondria in Age-Related Hearing Loss
  • 批准号:
    8433346
  • 项目类别:
  • 资助金额:
    $45.17万
  • 财政年份:
    2012
  • 负责人:
    TOMAS ALBERTO PROLLA
  • 依托单位:
The Role of mitochondria in Age-Related Hearing Loss
  • 批准号:
    8607929
  • 项目类别:
  • 资助金额:
    $43.24万
  • 财政年份:
    2012
  • 负责人:
    TOMAS ALBERTO PROLLA
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: